Andrew L. Taylor
2023
In 2023, Andrew L. Taylor earned a total compensation of $2.4M as Chief Financial Officer at Orchestra BioMed Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $99,367 |
|---|---|
| Salary | $227,000 |
| Stock Awards | $2,065,453 |
| Total | $2,391,820 |
Taylor received $2.1M in stock awards, accounting for 86% of the total pay in 2023.
Taylor also received $99.4K in non-equity incentive plan and $227K in salary.
Rankings
In 2023, Andrew L. Taylor's compensation ranked 425th out of 2,978 executives tracked by ExecPay. In other words, Taylor earned more than 85.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 425 out of 2,978 | 86th |
Division Manufacturing | 240 out of 1,637 | 85th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 25 out of 256 | 90th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 20 out of 188 | 89th |
Industry Surgical and Medical Instruments and Apparatus | 19 out of 144 | 87th |
Source: SEC filing on April 30, 2024.
Taylor's colleagues
We found two more compensation records of executives who worked with Andrew L. Taylor at Orchestra BioMed Holdings in 2023.